DE3850728D1 - Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen. - Google Patents

Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.

Info

Publication number
DE3850728D1
DE3850728D1 DE3850728T DE3850728T DE3850728D1 DE 3850728 D1 DE3850728 D1 DE 3850728D1 DE 3850728 T DE3850728 T DE 3850728T DE 3850728 T DE3850728 T DE 3850728T DE 3850728 D1 DE3850728 D1 DE 3850728D1
Authority
DE
Germany
Prior art keywords
drugs
animal
behavior
drug
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850728T
Other languages
English (en)
Other versions
DE3850728T2 (de
Inventor
Hiroyuki Ohhara
Akio Namimatsu
Hirohide Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of DE3850728D1 publication Critical patent/DE3850728D1/de
Application granted granted Critical
Publication of DE3850728T2 publication Critical patent/DE3850728T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
DE3850728T 1987-09-22 1988-09-22 Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen. Expired - Fee Related DE3850728T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62238006A JPS6479657A (en) 1987-09-22 1987-09-22 Vital decision of medicine

Publications (2)

Publication Number Publication Date
DE3850728D1 true DE3850728D1 (de) 1994-08-25
DE3850728T2 DE3850728T2 (de) 1994-12-22

Family

ID=17023739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850728T Expired - Fee Related DE3850728T2 (de) 1987-09-22 1988-09-22 Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.

Country Status (5)

Country Link
US (1) US4996988A (de)
EP (1) EP0308926B1 (de)
JP (1) JPS6479657A (de)
AT (1) ATE108906T1 (de)
DE (1) DE3850728T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6234965B1 (en) * 1998-03-31 2001-05-22 Scientific Learning Corporation Methods and apparatus for improving biochemical based therapy in humans
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
US20100048408A1 (en) * 2006-09-06 2010-02-25 Nippon Zoki Pharmaceutical Co., Ltd. Method for study, determination or evaluation by gene expression analysis
WO2011017835A1 (en) * 2009-08-11 2011-02-17 Nanjing University Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
CA2909234C (en) 2013-04-30 2023-03-14 Nippon Zoki Pharmaceutical Co., Ltd. Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus
US20150031004A1 (en) 2013-07-24 2015-01-29 Lumos Labs, Inc. Physically intuitive, real-time, multiple object tracking, planning and divided attention task for enhancing cognition
CN111511403A (zh) * 2017-12-28 2020-08-07 学校法人兵库医科大学 脂质运载蛋白型前列腺素d2合成酶产生促进剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU506395A1 (ru) * 1974-06-10 1976-03-15 Всесоюзный научно-исследовательский институт ветеринарной санитарии Способ токсикологического исследовани м са животных, вынужденно забитых при фузариотоксикозе
SU656099A1 (ru) * 1977-09-06 1979-04-05 Научно-Исследовательский Институт Эпидемиологии, Микробиологии И Инфекционных Болезней Способ моделировани реакций клеточной гиперчувствительности
SU1076810A1 (ru) * 1981-05-29 1984-02-29 Институт питания АМН СССР Способ определени безвредности продуктов питани
US4537747A (en) * 1983-03-16 1985-08-27 Chemetrics, Inc. Disposable device for sampling and diluting
US4535786A (en) * 1983-07-25 1985-08-20 Kater John A R Measurement of body fluid chemistry
SU1187793A1 (ru) * 1984-01-31 1985-10-30 Do G Med I Im A M Gorkogo Способ диагностики острого панкреатита
US4677968A (en) * 1986-01-14 1987-07-07 University Of Utah Research Foundation Methods of testing the reaction of various substances on living human skin

Also Published As

Publication number Publication date
EP0308926A3 (en) 1990-07-11
ATE108906T1 (de) 1994-08-15
US4996988A (en) 1991-03-05
DE3850728T2 (de) 1994-12-22
EP0308926B1 (de) 1994-07-20
EP0308926A2 (de) 1989-03-29
JPH0565106B2 (de) 1993-09-17
JPS6479657A (en) 1989-03-24

Similar Documents

Publication Publication Date Title
Hultén et al. Dynamics in serum of the inflammatory markers serum amyloid A (SAA), haptoglobin, fibrinogen and α2‐globulins during induced noninfectious arthritis in the horse
Dubový et al. Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain
DE69533942D1 (de) Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen
Perlmann et al. Changes in the electrophoretic pattern in lymph and serum in experimental burns
BR9908165A (pt) Processos de prevenção de um citotóxico de proteìna beta amilóide em células, de tratamento de uma fibrilogênica em um sujeito humano, de diminuição da oxidação em uma amostra biológica e de tratamento de doenças ou outros quadros em que radicais livres e/ou tensão oxidativa desempenham um papel, e, uso de ácido indol-3-propiÈnico ou um seu sal ou éster.
DE69130289D1 (de) Therapeutische verwendung von actin-bindenden verbindungen
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
Chakder et al. Evidence for VIP-induced increase in NO production in myenteric neurons of opossum internal anal sphincter
Virchenko et al. Independent and additive stimulation of tendon repair by thrombin and plateletss
Shytikov et al. Aged mice repeatedly injected with plasma from young mice: a survival study
DE3850728D1 (de) Methode zur Bestimmung des Verhaltens von Medikamenten in Lebewesen.
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
DE69110289D1 (de) Verabreichung von wirkstoffen zu wassertieren mittels überschallen.
FR2476320A1 (fr) Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif
ATE537823T1 (de) Verfahren zur behandlung von präeklampsie beim menschen mit resibufagenin
Zbóril et al. S100B protein and neuron-specific enolase as predictors of postoperative cognitive dysfunction in aged dogs: a case-control study
DOERR et al. New evidence for intrinsic blood coagulation in chickens
Pai et al. Kinetics of aluminum in rats I: Dose‐dependent elimination from blood after intravenous administration
Mulvihill et al. An investigation of factors influencing the bioavailability of non-heam iron from meat systems
SE8701437D0 (sv) Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet
Smeller et al. A physiological study of immobilized cheetahs (Acinonyx jubatus)
Popiel et al. Antipruritic application of ovocystatin in atopic dermatitis in dogs-preliminary study
Mößeler et al. NBT‐PABA test to assess efficiency and kinetics of substituted proteolytic enzyme action in pancreatic duct ligated minipigs
van den Besselaar Standardization of the activated partial thromboplastin time for monitoring of heparin therapy: where should we go?

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee